XNK Therapeutics appoints Dr. Johan Aschan as Chief Medical Officer
April 14, 2021 XNK Therapeutics AB (“XNK”) today announced the appointment of Dr. Johan Aschan as Chief Medical Officer, effective July 1[st]. He will be member of the company’s management team.Dr. Aschan received his MD from Karolinska Institutet (KI) in 1985 and his PhD in Clinical Immunology from KI in 1994. He has extensive experience from work within the field of allogenic stem cell transplantation at the Karolinska University Hospital in Huddinge, Sweden, and from various leadership roles within hematology and oncology at Janssen. Most recently, prior to joining XNK, Dr. Aschan